Cyclooxygenase Inhibitors
"Cyclooxygenase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.
| Descriptor ID |
D016861
|
| MeSH Number(s) |
D27.505.519.389.310 D27.505.696.663.850.014.040.500.500 D27.505.954.158.030.500 D27.505.954.329.030.500
|
| Concept/Terms |
Cyclooxygenase Inhibitors- Cyclooxygenase Inhibitors
- Inhibitors, Cyclo-Oxygenase
- Inhibitors, Cyclo Oxygenase
- Inhibitors, Cyclooxygenase
- Prostaglandin Synthesis Antagonists
- Antagonists, Prostaglandin Synthesis
- Inhibitors, Prostaglandin-Endoperoxide Synthase
- Inhibitors, Prostaglandin Endoperoxide Synthase
- Prostaglandin Endoperoxide Synthase Inhibitors
- Prostaglandin Synthase Inhibitors
- Cyclo-Oxygenase Inhibitors
- Cyclo Oxygenase Inhibitors
- Inhibitors, Prostaglandin Synthase
|
Below are MeSH descriptors whose meaning is more general than "Cyclooxygenase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cyclooxygenase Inhibitors".
This graph shows the total number of publications written about "Cyclooxygenase Inhibitors" by people in this website by year, and whether "Cyclooxygenase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclooxygenase Inhibitors" by people in Profiles.
-
Preserved ß-adrenergic-mediated vasodilation in skeletal muscle of young adults with obesity despite shifts in cyclooxygenase and nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2022 01 01; 322(1):H25-H35.
-
Differential contribution of cyclooxygenase to basal cerebral blood flow and hypoxic cerebral vasodilation. Am J Physiol Regul Integr Comp Physiol. 2020 02 01; 318(2):R468-R479.
-
Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice. Geroscience. 2017 12; 39(5-6):601-614.
-
ß-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2016 Mar 15; 310(6):H756-64.
-
Pharmacologically-induced neurovascular uncoupling is associated with cognitive impairment in mice. J Cereb Blood Flow Metab. 2015 Nov; 35(11):1871-81.
-
Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase. Eur J Appl Physiol. 2015 Aug; 115(8):1735-46.
-
Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages. Cancer Prev Res (Phila). 2013 Mar; 6(3):206-16.
-
Protective strategies to prevent patent ductus arteriosus. Chin Med J (Engl). 2010 Oct; 123(20):2914-8.
-
Treatment of patent ductus arteriosus: indomethacin or ibuprofen? J Perinatol. 2008 May; 28 Suppl 1:S60-2.
-
Regulation of COX and LOX by curcumin. Adv Exp Med Biol. 2007; 595:213-26.